Social Media Chatbot on Physical Activity Education for Older Adults
Launched by TAIPEI MEDICAL UNIVERSITY · May 15, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a social media chatbot can help older adults improve their physical activity and confidence in exercising. Over the course of 8 weeks, participants will receive daily multimedia health education about physical activity, along with real-time feedback and supportive messages through the Line app. The goal is to see if this approach can encourage more regular exercise and help older adults feel more capable of staying active.
To be eligible for this study, participants need to be between 60 and 85 years old, live in Taipei City, and be able to read, write, and listen to Chinese. They should also have used a smartphone recently and be comfortable using the Line app. However, those who have serious health issues that prevent them from exercising, or who require supervision while exercising, cannot participate. If you join the study, you will complete some questionnaires about your physical activity and exercise confidence, and you'll have the chance to engage with helpful resources designed to support your health and well-being.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Persons aged 60 to 85 years old living in Taipei City, healthy or with chronic conditions
- • 2. Those who can listen, read and write Chinese
- • 3. Those who have used smartphones in the past month and can use Line social software
- • 4. Those who voluntarily participate in this study, can understand the research content after explanation and explanation, and sign the subject consent form
- Exclusion Criteria:
- • 1. Those who are advised by a doctor not to exercise
- • 2. Those who must exercise under the supervision of medical personnel
- • 3. Patients with severe cardiovascular disease
- • 4. Anyone with disability or cognitive impairment
- • 5. Persons living in long-term care institutions
About Taipei Medical University
Taipei Medical University (TMU) is a leading educational and research institution located in Taipei, Taiwan, dedicated to advancing health sciences and clinical research. Established with a focus on fostering innovation in medical education, TMU integrates comprehensive clinical training with rigorous research methodologies. The university is committed to improving patient outcomes through a strong emphasis on translational medicine and interdisciplinary collaboration. TMU's clinical trial initiatives are designed to explore new treatments and therapies, contributing to the global body of medical knowledge while adhering to the highest ethical standards and regulatory compliance.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei City, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported